GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $443,000 | -96.9% | 17,424 | -93.3% | 0.00% | -97.8% |
| Q3 2020 | $14,290,000 | -57.7% | 259,168 | -51.6% | 0.09% | -58.7% |
| Q2 2020 | $33,792,000 | +676.6% | 535,276 | +528.5% | 0.22% | +575.8% |
| Q1 2020 | $4,351,000 | +1868.8% | 85,168 | +2968.0% | 0.03% | +3200.0% |
| Q4 2019 | $221,000 | -41.5% | 2,776 | -64.4% | 0.00% | -50.0% |
| Q3 2019 | $378,000 | -93.7% | 7,790 | -94.1% | 0.00% | -94.1% |
| Q2 2018 | $5,979,000 | +769.0% | 132,283 | +496.5% | 0.03% | +750.0% |
| Q3 2017 | $688,000 | -0.9% | 22,178 | +18.3% | 0.00% | -20.0% |
| Q1 2017 | $694,000 | – | 18,751 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |